Hand Sanitizer (Pharmacies) - NAFTA

NAFTA

Highlights

Revenue in the Hand Sanitizer market is projected to reach US$443.60m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.10%, resulting in a market volume of US$542.40m by 2029.
In global comparison, most revenue will be generated China (US$385.20m in 2024).
In relation to total population figures, per person revenues of US$0.87 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Hand Sanitizer (Pharmacies) market in NAFTA has been experiencing significant growth in recent years. Customer preferences for hand sanitizers have shifted towards products that are more effective in killing germs and bacteria. Additionally, there has been an increased focus on the importance of hand hygiene, especially in the healthcare sector. These factors have contributed to the rising demand for hand sanitizers in pharmacies across the NAFTA region.

Customer preferences: Customers in the NAFTA region are increasingly looking for hand sanitizers that offer maximum protection against germs and bacteria. They prefer products that have a high alcohol content, as alcohol is known to be effective in killing a wide range of germs. Additionally, customers are also seeking hand sanitizers that are gentle on the skin and do not cause dryness or irritation. This has led to the development of hand sanitizers with moisturizing properties, which are preferred by customers with sensitive skin.

Trends in the market: One of the key trends in the Hand Sanitizer (Pharmacies) market in NAFTA is the increasing demand for natural and organic hand sanitizers. Customers are becoming more conscious of the ingredients used in the products they use, and are opting for hand sanitizers that are free from harsh chemicals and artificial fragrances. This trend is driven by the growing awareness of the potential harmful effects of certain chemicals found in traditional hand sanitizers. Another trend in the market is the growing popularity of travel-sized hand sanitizers. With increasing travel and on-the-go lifestyles, customers are looking for convenient and portable hand sanitizers that can be easily carried in their bags or pockets. This trend has led to the introduction of smaller-sized hand sanitizers that are specifically designed for travel purposes.

Local special circumstances: In the United States, the Hand Sanitizer (Pharmacies) market has been influenced by the COVID-19 pandemic. The outbreak of the virus has significantly increased the demand for hand sanitizers, leading to shortages in supply. As a result, many pharmacies have implemented purchase limits to ensure that there is enough supply for all customers. Additionally, there has been a surge in online sales of hand sanitizers, as customers seek alternative sources to purchase the product. In Canada, the Hand Sanitizer (Pharmacies) market has also witnessed a surge in demand due to the COVID-19 pandemic. The government has implemented regulations to ensure the availability of hand sanitizers and other essential products. This has led to an increase in domestic production of hand sanitizers, with many distilleries and other companies shifting their production to meet the demand.

Underlying macroeconomic factors: The growth of the Hand Sanitizer (Pharmacies) market in NAFTA can be attributed to several macroeconomic factors. The increasing awareness of the importance of hand hygiene, coupled with the rise in infectious diseases, has driven the demand for hand sanitizers. Additionally, the growing healthcare sector in the region, along with the implementation of strict hygiene regulations, has further fueled the market growth. The availability of a wide range of hand sanitizers in pharmacies, along with the convenience of purchasing them, has also contributed to the market expansion. Overall, the Hand Sanitizer (Pharmacies) market in NAFTA is expected to continue growing in the coming years, driven by customer preferences and the prevailing macroeconomic factors.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.